WASHINGTON, D.C. (April 30, 2007) – Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), issued the following statement on today’s Supreme Court ruling in the case of KSR International Co. versus Teleflex, Inc.:
“Our decision to file a brief in this case had less to do with the specific facts of this case than with the general principle that courts have to proceed carefully in declaring patents obvious based on prior art. Upon first blush, the Supreme Court appears to agree that courts need to apply a careful and deliberate analysis to the question of obviousness, focusing on the predictability of the results of the invention. The impact of the decision on the biotechnology sector will be determined by how the opinion is applied by lower court judges and PTO examiners.”
BIO’s amicus brief on the case can be accessed at http://bio.org/ip/amicus/KSR.pdf.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the global event for biotechnology.
Upcoming BIO Events
· BIO International Convention
May 6-9, 2007
· BIO VentureForum-East 2007
June 18-20, 2007
· BIO Mid-America VentureForum 2007
Sep. 24–26, 2007